271 related articles for article (PubMed ID: 16320247)
1. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features.
Christacos NC; Quade BJ; Dal Cin P; Morton CC
Genes Chromosomes Cancer; 2006 Mar; 45(3):304-12. PubMed ID: 16320247
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
[TBL] [Abstract][Full Text] [Related]
3. Genetic heterogeneity among uterine leiomyomata: insights into malignant progression.
Hodge JC; Morton CC
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R7-13. PubMed ID: 17613550
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.
Hodge JC; Quade BJ; Rubin MA; Stewart EA; Dal Cin P; Morton CC
Am J Pathol; 2008 May; 172(5):1403-10. PubMed ID: 18403592
[TBL] [Abstract][Full Text] [Related]
5. Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: a combined comparative genomic hybridization and microsatellite analysis.
Zahn S; Sievers S; Alemazkour K; Orb S; Harms D; Schulz WA; Calaminus G; Göbel U; Schneider DT
Genes Chromosomes Cancer; 2006 Nov; 45(11):995-1006. PubMed ID: 16897744
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma.
Herzog TJ; Kowalski LD; Liu H; Arlt M; Swisher E
Gynecol Oncol; 2001 Jul; 82(1):139-42. PubMed ID: 11426975
[TBL] [Abstract][Full Text] [Related]
7. Microarray-based CGH of sporadic and syndrome-related pheochromocytomas using a 0.1-0.2 Mb bacterial artificial chromosome array spanning chromosome arm 1p.
Aarts M; Dannenberg H; deLeeuw RJ; van Nederveen FH; Verhofstad AA; Lenders JW; Dinjens WN; Speel EJ; Lam WL; de Krijger RR
Genes Chromosomes Cancer; 2006 Jan; 45(1):83-93. PubMed ID: 16215979
[TBL] [Abstract][Full Text] [Related]
8. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
[TBL] [Abstract][Full Text] [Related]
9. HMGA2 expression in uterine leiomyomata and myometrium: quantitative analysis and tissue culture studies.
Gross KL; Neskey DM; Manchanda N; Weremowicz S; Kleinman MS; Nowak RA; Ligon AH; Rogalla P; Drechsler K; Bullerdiek J; Morton CC
Genes Chromosomes Cancer; 2003 Sep; 38(1):68-79. PubMed ID: 12874787
[TBL] [Abstract][Full Text] [Related]
10. Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p.
Mukasa A; Ueki K; Matsumoto S; Tsutsumi S; Nishikawa R; Fujimaki T; Asai A; Kirino T; Aburatani H
Oncogene; 2002 Jun; 21(25):3961-8. PubMed ID: 12037678
[TBL] [Abstract][Full Text] [Related]
11. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.
Hodge JC; Kim TM; Dreyfuss JM; Somasundaram P; Christacos NC; Rousselle M; Quade BJ; Park PJ; Stewart EA; Morton CC
Hum Mol Genet; 2012 May; 21(10):2312-29. PubMed ID: 22343407
[TBL] [Abstract][Full Text] [Related]
12. Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: genetic linkage analysis and FISH studies.
Gross KL; Panhuysen CI; Kleinman MS; Goldhammer H; Jones ES; Nassery N; Stewart EA; Morton CC
Genes Chromosomes Cancer; 2004 Nov; 41(3):183-90. PubMed ID: 15334541
[TBL] [Abstract][Full Text] [Related]
13. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
Välimäki S; Forsberg L; Farnebo LO; Larsson C
Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
[TBL] [Abstract][Full Text] [Related]
14. Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis.
Bardi G; Pandis N; Fenger C; Kronborg O; Bomme L; Heim S
Cancer Res; 1993 Apr; 53(8):1895-8. PubMed ID: 8467511
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiles associated with treatment response in oligodendrogliomas.
French PJ; Swagemakers SM; Nagel JH; Kouwenhoven MC; Brouwer E; van der Spek P; Luider TM; Kros JM; van den Bent MJ; Sillevis Smitt PA
Cancer Res; 2005 Dec; 65(24):11335-44. PubMed ID: 16357140
[TBL] [Abstract][Full Text] [Related]
16. Chromosome aberrations in uterine smooth muscle tumors: potential diagnostic relevance of cytogenetic instability.
Fletcher JA; Morton CC; Pavelka K; Lage JM
Cancer Res; 1990 Jul; 50(13):4092-7. PubMed ID: 2354458
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP
Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
Spitz R; Hero B; Westermann F; Ernestus K; Schwab M; Berthold F
Genes Chromosomes Cancer; 2002 Jul; 34(3):299-305. PubMed ID: 12007190
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of 1p35-36 genes in neuroblastoma.
Janoueix-Lerosey I; Novikov E; Monteiro M; Gruel N; Schleiermacher G; Loriod B; Nguyen C; Delattre O
Oncogene; 2004 Aug; 23(35):5912-22. PubMed ID: 15195138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]